Cost-effectiveness Analysis of Therapeutic Scheme for Nongonococcal Urethritis(cervicitis)

梁新亮,赵红卫,张守民,史素娥
DOI: https://doi.org/10.3760/cma.j.issn.1008-6706.2002.11.011
2002-01-01
Abstract:Objective To evaluate the economic effectiveness of three antibiotic therapeutic schemes for nongonococcal urethritis(cervicitis).Methods Three groups of total 157 patients suffering from nongonococcal urethritis(cervicitis) were treated with clarimycin,roxithromycin,and levofloxacin,respectively.The schemes were evaluated with pharmacoeconomic cost effectiveness analysis.Results Charimycin was the best in the three schemes from either cost effectiveness analysis(C/E) or increasing cost effectiveness analysis(△C/△E).Conclusion Pharmacoeconomics is very useful in optimizing therapeutic scheme.
What problem does this paper attempt to address?